Traders Sell Shares of Zoetis Inc. (ZTS) on Strength (ZTS)
Traders sold shares of Zoetis Inc. (NYSE:ZTS) on strength during trading on Friday. $16.82 million flowed into the stock on the tick-up and $38.15 million flowed out of the stock on the tick-down, for a money net flow of $21.33 million out of the stock. Of all equities tracked, Zoetis had the 0th highest net out-flow for the day. Zoetis traded up $0.29 for the day and closed at $50.76
Several equities research analysts have weighed in on the company. Guggenheim reissued a “positive” rating and set a $60.00 price objective on shares of Zoetis in a research note on Monday, August 22nd. Jefferies Group reissued a “buy” rating and set a $60.00 price objective on shares of Zoetis in a research note on Tuesday. Credit Suisse Group AG reissued an “outperform” rating and set a $60.00 price objective on shares of Zoetis in a research note on Tuesday. Barclays PLC boosted their price objective on Zoetis from $45.00 to $49.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 4th. Finally, Citigroup Inc. boosted their price objective on Zoetis from $50.00 to $53.00 and gave the stock a “neutral” rating in a research note on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company’s stock. Zoetis presently has a consensus rating of “Buy” and an average target price of $54.79.
The stock has a 50-day moving average of $50.61 and a 200 day moving average of $46.65. The stock has a market cap of $25.13 billion and a P/E ratio of 39.53.
Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Wednesday, August 3rd. The company reported $0.49 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.44 by $0.05. The company earned $1.20 billion during the quarter, compared to analysts’ expectations of $1.17 billion. During the same period in the prior year, the business posted $0.43 earnings per share. The company’s quarterly revenue was up 2.8% compared to the same quarter last year. Equities analysts expect that Zoetis Inc. will post $1.90 EPS for the current year.
A hedge fund recently raised its stake in Zoetis stock. Schwab Charles Investment Management Inc. raised its position in Zoetis Inc. (NYSE:ZTS) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,491,364 shares of the company’s stock after buying an additional 31,045 shares during the period. Schwab Charles Investment Management Inc. owned 0.30% of Zoetis worth $71,467,000 as of its most recent filing with the SEC.
Zoetis Inc is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Company has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals.